Akari Therapeutics Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Akari Therapeutics Plc on June 25, 2019. The filing serves as a notification to shareholders regarding a logistical change to the location of the Company's Annual General Meeting (AGM) scheduled for June 27, 2019.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
The primary material change disclosed is the relocation of the AGM venue due to recent water damage at the originally scheduled location (Chandos House, 2 Queen Anne Street). The meeting will commence at the original site at 2:00 p.m. local time solely to adjourn immediately to 1 Wimpole Street, London (CUHK meeting room), at 2:15 p.m. local time.
Guidance, Outlook, and Risks
Management commentary is limited to the logistical details of the venue change. The filing explicitly states that the business to be conducted remains as set out in the original notice of meeting. There are no changes to voting procedures, and existing proxy instructions remain valid. No new risks, contingencies, or unusual items were disclosed in this report.
Key Facts for Investor Verification
- The AGM date remains June 27, 2019.
- The meeting will adjourn from Chandos House to 1 Wimpole Street due to water damage.
- Existing proxy voting instructions are unaffected and remain valid.
- No financial data or strategic updates are included in this filing.